# Feasibility and Performance Evaluation of INVSENSOR00024

> **NCT03831282** · NA · COMPLETED · sponsor: **Masimo Corporation** · enrollment: 12 (actual)

## Conditions studied

- Evaluation of SpO2 Performance

## Interventions

- **DEVICE:** RD SET Neo SpO2

## Key facts

- **NCT ID:** NCT03831282
- **Lead sponsor:** Masimo Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-08
- **Primary completion:** 2019-05-28
- **Final completion:** 2019-05-28
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831282, "Feasibility and Performance Evaluation of INVSENSOR00024". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03831282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*